AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Viflink M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Epione Pharma Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Viflink M 500mg/50mg Tablet

Diabetic patients with type 2 mellitus may find relief with Viflink M 500mg/50mg tablets, a dual-action medication regulating elevated blood glucose. This synergistic approach mitigates the risk of severe diabetic complications, such as renal impairment and visual loss, while potentially lessening the likelihood of cardiovascular events. Viflink M 500mg/50mg may be utilized as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved when coupled with a balanced diet and consistent physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar management helps prevent future health issues. Adherence to the prescribed diet and exercise plan is crucial for overall diabetes management; lifestyle choices significantly influence disease control. Commonly reported adverse events include nausea, vomiting, diarrhea, abdominal distress, headache, pharyngitis, asthenia, gastroesophageal reflux, diaphoresis, and anorexia. Hypoglycemia, particularly if combined with insulin or sulfonylureas, is a potential risk, necessitating patient awareness of its symptoms and management. Prior to initiating treatment, individuals with pre-existing renal, hepatic, or cardiac conditions, pancreatic dysfunction, or significant alcohol consumption should inform their physician. Pregnant or lactating women should seek medical counsel before use. To ensure medication safety, disclose all current medications to your doctor, as interactions may occur. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout treatment.

Uses of Viflink M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Viflink M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Viflink M 500mg/50mg Tablet whole; do not break, crush, or chew it. Administer this medicine with food.

Common Side effects of Viflink M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Viflink M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Viflink M 500mg/50mg Tablets should be administered with a meal.

How Viflink M 500mg/50mg Tablet works:

The dual-action antidiabetic tablet, Viflink M 500mg/50mg, combines two distinct medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Viflink M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Viflink M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescription. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Viflink M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Viflink M 500mg/50mg Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Viflink M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Viflink M 500mg/50mg Tablet :

Should you forget to take a Viflink M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Viflink M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Viflink M 500mg/50mg Tablet

Viflink M 500mg/50mg tablets rarely cause hypoglycemia (low blood sugar) by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Viflink M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without first consulting your doctor.
Viflink M 500mg/50mg Tablet is contraindicated in patients with known allergies to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Viflink M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Viflink M 500mg/50mg Tablet can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. While rare, this side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Viflink M 500mg/50mg Tablet and seek immediate medical attention.
Prolonged use of Viflink M 500mg/50mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Viflink M 500mg/50mg Tablet is safe when used as directed by your doctor. While following the prescribed dosage, you may still experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially with insulin or sulphonylurea). Report any persistent issues to your doctor.
Viflink M 500mg/50mg Tabl...
73
MRP 85
14% off